心理健康研究中神经多样性与神经殊异性关联的临床诊断范围综述
参与者主要通过自报诊断或自我认同界定,关联诊断最常见为孤独症、ADHD、阅读障碍等,但诊断谱系异质且约两成研究未明确任何临床诊断。作者提示术语缺乏诊断特异性,临床与研究应优先使用精确诊断描述词。
要点
- 神经殊异性/神经多样性相关研究参与者多经自报诊断或自我认同界定,诊断谱系高度异质。
- 最常关联诊断为孤独症(68.7%)与ADHD(64.2%),焦虑障碍仅14.9%。
- 21.6%的研究未明确任何临床诊断,提示术语使用缺乏诊断特异性。
核心结论
- 神经殊异性和神经多样性术语虽有助于捕捉生活体验,但缺乏特异性,可能在以临床类别为焦点的研究中引入显著异质性。
- 建议在涉及临床定义状况的临床实践与研究中优先使用精确诊断描述词,而将神经殊异性保留用于聚焦自我认同与身份的研究和情境。
研究设计与样本
- 范围综述,遵循JBI方法与PRISMA-ScR扩展,由具备生活经验专家共同参与。
主要发现
- 参与者主要通过自报诊断(56项,41.8%)或自我认同(50项,37.3%)界定。
- 关联诊断谱系异质,最常见为孤独症(92项,68.7%),其次ADHD(86项,64.2%)、阅读障碍(44项,32.8%)、运用障碍(21项,15.7%)、焦虑障碍(20项,14.9%)、计算障碍(17项,12.7%)。
- 29项研究(21.6%)未明确任何临床诊断。
关键数值与推荐
- 自报诊断界定参与者56项(41.8%),自我认同界定50项(37.3%)。
- 孤独症92项(68.7%),ADHD 86项(64.2%),阅读障碍44项(32.8%),运用障碍21项(15.7%),焦虑障碍20项(14.9%),计算障碍17项(12.7%)。
- 未明确任何临床诊断的研究29项(21.6%)。
临床怎么用
- 在精神心理科临床与研究中,涉及临床定义状况时应使用精确诊断描述词,避免仅以神经殊异性/神经多样性笼统指代。
- 可将神经殊异性术语保留用于聚焦自我认同与身份的情境,以尊重生活体验同时减少诊断异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The terms neurodivergence and neurodiversity are increasingly used across mental health and broader clinical literature, as well as in clinical practice, clinical service commissioning, and policy contexts, despite their lack of clinical and diagnostic specificity. OBJECTIVE: To quantitively map clinical diagnoses associated with the terms neurodivergence and neurodiversity in the empirical mental health literature through a scoping review conducted with experts with lived experience . EVIDENCE REVIEW: Following JBI methods and the PRISMA extension for scoping reviews, PubMed/Medline, Web of Science, Embase, and PsycINFO were searched up to August 1, 2025, and identified 134 studies including 151 134 participants that recruited participants defined as neurodivergent or neurodiverse. FINDINGS: Participants were primarily identified through self-reported diagnoses (n = 56 [41.8%]) or self-identification (n = 50 [37.3%]). A heterogeneous range of diagnoses was associated with neurodivergence and neurodiversity, most commonly autism (n = 92 [68.7%]), followed by ADHD (n = 86 [64.2%]), dyslexia (n = 44 [32.8%]), dyspraxia (n = 21 [15.7%]), anxiety disorder (n = 20 [14.9%]), and dyscalculia (n = 17 [12.7%]). Notably, 29 studies (21.6%) did not specify any clinical diagnoses. CONCLUSIONS AND RELEVANCE: While neurodivergence and neurodiversity are valuable for capturing lived experience, their lack of specificity may introduce substantial heterogeneity in research focused on clinical categories. These findings suggest prioritizing precise diagnostic descriptors in clinical practice and research involving clinically defined conditions, while reserving neurodivergent for studies and contexts focused on self-identification and identity.
引用
- Bellato A, Long MRP, Barilà M, et al. Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review. JAMA Psychiatry. 2026. PMID: 42747846. doi:10.1001/jamapsychiatry.2026.2851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。